Diabetes Simplified 2023
Interested in continuing professional development focused on practical interpretations of the Diabetes Canada Clinical Practice Guidelines (CPG)?
Our free 2023 Diabetes Simplified program features six sessions that include two new topics from the CPG update. We’re also offering a new session, “Diabetes Every Day: A Case-Based Review of Select Topics Seen Frequently in Clinical Practice.”
This group learning program has been reviewed and certified by the College of Family Physicians of Canada and their national office.
Join us in person if you’re attending Vascular 2023, or online.
Overall learning objectives:
- Describe when and how to help people living with type 2 diabetes attain diabetes remission.
- Apply recently published CPG and pharmacotherapy evidence to managing patients living with type 2 diabetes.
- Describe the CPG recommendations for the management of mental health disorders and diabetes.
- Manage common diabetes patient case scenarios seen commonly in clinical practice.
When: October 25, 1 – 5 p.m. (ET)
Where: Le Westin Montreal (or online)
Cost: Free
Location Details
October 25, 2023
1:00 p.m. - 5:00 p.m. ET
In-person or virtual event
Le Westin Montréal
270 Rue Saint-Antoine Ouest
Montréal, QC
H2Y 0A3
About the event
Faculty
1. Remission of Type 2 Diabetes
- Assess patients in clinical practice who may be candidates for diabetes remission
- Explain to patients the benefits and long-term success rates of diabetes remission
- Discuss the evidence to support different treatment strategies to attain diabetes remission
- Explore how to translate and practically incorporate remission guidelines into practice
2. Pharmacotherapy refresher and update
- Determine when and how to initiate basal insulin in people with type 2 diabetes
- Discuss the role of SGLT2 inhibitors in people with diabetes and heart failure with preserved ejection fraction (HFpEF)
- Examine current Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guidelines for Diabetes Management in Chronic Kidney Disease (CKD)
- Discuss the evidence supporting the combination of a SGLT2 inhibitor and a GLP-1 receptor agonist
3. Diabetes and mental health
- Discuss the bidirectional relationship between diabetes and mental health disorders
- Screen people for diabetes distress and mental health disorders
- Apply 2023 CPG recommendations to managing patients with diabetes and mental health disorders
4. Gestational diabetes
- Screen a patient for gestational diabetes according to current guideline recommendations
- Determine the optimal targets and management for patients with gestational diabetes
- Discuss monitoring recommendations for gestational diabetes during and post-pregnancy
5. Dermatology and diabetes
- Discuss skin conditions/presentations seen in people with diabetes
- Determine the management of common dermatological conditions in people with diabetes
- Screen people with diabetes for foot ulcers according to current CPG recommendations
6. Screening, managing, and diagnosing NAFLD
- Discuss the prevalence, prognosis, and progression of non-alcoholic fatty liver disease (NAFLD) in people with type 2 diabetes
- Assess the person with type 2 diabetes and NAFLD according to current guidelines
- Determine the current and future management strategies of people with type 2 diabetes and NAFLD
This program has been developed in partnership with Partners in Progressive Medical Education (PPME).
